ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
24.81
+1.38 (5.89%)
Mar 9, 2026, 4:00 PM EDT - Market closed
ArriVent BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,097 | 831 | 898 | - | - | - |
| Market Cap Growth | 18.82% | -7.48% | - | - | - | - |
| Enterprise Value | 793 | 530 | 615 | - | - | - |
| Last Close Price | 23.43 | 20.12 | 26.64 | - | - | - |
| PB Ratio | 3.24 | 2.70 | 3.48 | - | - | - |
| P/TBV Ratio | 3.60 | 2.70 | 3.48 | - | - | - |
| Debt / Equity Ratio | 0 | 0 | 0.00 | 0.00 | 0.00 | - |
| Net Debt / Equity Ratio | -1.02 | -1.02 | -0.85 | -0.99 | -0.94 | -0.90 |
| Quick Ratio | 12.06 | 12.06 | 12.70 | 13.00 | 19.60 | 20.64 |
| Current Ratio | 12.83 | 12.83 | 13.14 | 13.76 | 21.85 | 23.63 |
| Return on Equity (ROE) | -58.88% | -58.88% | -39.36% | -42.57% | -34.22% | - |
| Return on Assets (ROA) | -36.49% | -36.49% | -26.91% | -26.95% | -20.42% | - |
| Return on Capital Employed (ROCE) | -57.80% | -57.80% | -36.60% | -49.20% | -21.20% | -28.10% |
| Earnings Yield | -15.04% | -20.02% | -8.97% | - | - | - |
| Buyback Yield / Dilution | -22.22% | -22.22% | -1369.88% | -67.64% | -79.57% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.